Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Schering-Plough, a science-centered healthcare company, has reported a net income of $805 million, or $0.46 per diluted share, for the first quarter ended March 31, 2009, compared to $314 million, or $0.17 per diluted share, for the first quarter ended March 31, 2008.
Subscribe to our email newsletter
The company has reported net income available to common shareholders of $767 million for the first quarter of 2009 compared to $276 million for the same quarter of 2008.
For the first quarter of 2009, net sales were $4.39 billion, compared to $4.66 billion in the same quarter of 2008.
Fred Hassan, chairman and CEO of Schering-Plough, said: “Schering-Plough powered through to deliver a solid performance in the first quarter. We overcame difficult currency comparisons and challenges in the US by driving operational sales growth in overseas markets and the continuing successful implementation of our Productivity Transformation Program.”